345 related articles for article (PubMed ID: 8626947)
1. A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty.
Grines CL; Schreiber TL; Savas V; Jones DE; Zidar FJ; Gangadharan V; Brodsky M; Levin R; Safian R; Puchrowicz-Ochocki S; Castellani MD; O'Neill WW
J Am Coll Cardiol; 1996 May; 27(6):1381-6. PubMed ID: 8626947
[TBL] [Abstract][Full Text] [Related]
2. Comparison of ionic and nonionic low osmolar contrast media in relation to thrombotic complications of angioplasty in patients with unstable angina.
Malekianpour M; Bonan R; Lespérance J; Gosselin G; Hudon G; Doucet S; Laurier J; Duval D
Am Heart J; 1998 Jun; 135(6 Pt 1):1067-75. PubMed ID: 9630113
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial comparing the impact of a nonionic (Iomeprol) versus an ionic (Ioxaglate) low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty.
Schräder R; Esch I; Ensslen R; Fach WA; Merle H; Scherer D; Sievert H; Spies HF; Zeplin HE
J Am Coll Cardiol; 1999 Feb; 33(2):395-402. PubMed ID: 9973019
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous coronary angioscopic comparison of thrombus formation during percutaneous coronary angioplasty with ionic and nonionic low osmolality contrast media in unstable angina.
Qureshi NR; den Heijer P; Crijns HJ
Am J Cardiol; 1997 Sep; 80(6):700-4. PubMed ID: 9315572
[TBL] [Abstract][Full Text] [Related]
5. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis.
Circulation; 1997 Sep; 96(5):1445-53. PubMed ID: 9315530
[TBL] [Abstract][Full Text] [Related]
6. A comparison of ionic versus nonionic contrast medium during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction (GUSTO IIb). Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes.
Batchelor WB; Granger CB; Kleiman NS; Phillips HR; Ellis SG; Betriu A; Criger DA; Stebbins AL; Topol EJ; Califf RM;
Am J Cardiol; 2000 Mar; 85(6):692-7. PubMed ID: 12000041
[TBL] [Abstract][Full Text] [Related]
7. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial Investigators.
Bertrand ME; Esplugas E; Piessens J; Rasch W
Circulation; 2000 Jan; 101(2):131-6. PubMed ID: 10637198
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive thrombolytic therapy during angioplasty for ischemic rest angina. Results of the TAUSA Trial. TAUSA Investigators. Thrombolysis and Angioplasty in Unstable Angina trial.
Ambrose JA; Almeida OD; Sharma SK; Torre SR; Marmur JD; Israel DH; Ratner DE; Weiss MB; Hjemdahl-Monsen CE; Myler RK
Circulation; 1994 Jul; 90(1):69-77. PubMed ID: 8026054
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive intracoronary dipyridamole in the interventional treatment of small coronary arteries: a prospectively randomized trial.
Heidland UE; Heintzen MP; Michel CJ; Strauer BE
Am Heart J; 2000 Jun; 139(6):1039-45. PubMed ID: 10827385
[TBL] [Abstract][Full Text] [Related]
10. Influence of contrast media on thrombus formation during coronary angioplasty.
Gasperetti CM; Feldman MD; Burwell LR; Angello DA; Haugh KH; Owen RM; Powers ER
J Am Coll Cardiol; 1991 Aug; 18(2):443-50. PubMed ID: 1856412
[TBL] [Abstract][Full Text] [Related]
11. Six-month angiographic and clinical follow-up of patients prospectively randomized to receive either tirofiban or placebo during angioplasty in the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis.
Gibson CM; Goel M; Cohen DJ; Piana RN; Deckelbaum LI; Harris KE; King SB
J Am Coll Cardiol; 1998 Jul; 32(1):28-34. PubMed ID: 9669245
[TBL] [Abstract][Full Text] [Related]
12. [Intracoronary dipyridamole reduces the incidence of acute coronary vessel occlusion in percutaneous transluminal coronary angioplasty--a prospective randomized study].
Heintzen MP; Heidland UE; Klimek WJ; Michel CJ; Kelm M; Leschke M; Schwartzkopff B; Vester EG; Strauer BE
Z Kardiol; 1997 Dec; 86(12):961-7. PubMed ID: 9499493
[TBL] [Abstract][Full Text] [Related]
13. Management of unstable coronary syndromes in patients with previous coronary artery bypass grafts following coronary angiography.
Chan AW; Ross J
Clin Invest Med; 1997 Oct; 20(5):320-6. PubMed ID: 9336657
[TBL] [Abstract][Full Text] [Related]
14. Comparison of results of intracoronary stenting in patients with unstable vs. stable angina.
Malosky SA; Hirshfeld JW; Herrmann HC
Cathet Cardiovasc Diagn; 1994 Feb; 31(2):95-101. PubMed ID: 8149437
[TBL] [Abstract][Full Text] [Related]
15. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.
Anderson HV; Cannon CP; Stone PH; Williams DO; McCabe CH; Knatterud GL; Thompson B; Willerson JT; Braunwald E
J Am Coll Cardiol; 1995 Dec; 26(7):1643-50. PubMed ID: 7594098
[TBL] [Abstract][Full Text] [Related]
16. Outcome of percutaneous transluminal coronary angioplasty in subsets of unstable angina pectoris. A report of the 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.
Bentivoglio LG; Detre K; Yeh W; Williams DO; Kelsey SF; Faxon DP
J Am Coll Cardiol; 1994 Nov; 24(5):1195-206. PubMed ID: 7930239
[TBL] [Abstract][Full Text] [Related]
17. Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients. Angiographic results from the CAPTURE trial.
van den Brand M; Laarman GJ; Steg PG; De Scheerder I; Heyndrickx G; Beatt K; Kootstra J; Simoons ML
Eur Heart J; 1999 Nov; 20(21):1572-8. PubMed ID: 10529325
[TBL] [Abstract][Full Text] [Related]
18. Early coronary angioplasty as compared with delayed coronary angioplasty in patients with high-risk unstable angina pectoris.
Antoniucci D; Santoro GM; Bolognese L; Leoncini M; Buonamici P; Valenti R; Fazzini PF
Coron Artery Dis; 1996 Jan; 7(1):75-80. PubMed ID: 8773437
[TBL] [Abstract][Full Text] [Related]
19. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous transluminal coronary angioplasty in unstable and stable angina pectoris: a comparison of immediate success and complications.
Ilia R; Kolansky D; Setaro J; Brennan J; Cabin H; Cleman M; Remetz M
Cardiology; 1992; 81(4-5):245-50. PubMed ID: 1301250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
